drugset / Trial / NCT00373815

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

NCT00373815 ↗

Phase 1 Terminated 10 enrolled University Hospital Tuebingen
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The present protocol is a dose-finding and toxicity study in preparation of a randomised study comparing current standard treatment CSA/prednisolone with the new combination CSA/prednisolone/everolimus.

Timeline

Start
2006-09
Primary completion
—
Completion
2009-10

Outcome

Outcome not reported

Stopped: “high incidence of TTP, poor recrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule — Oral